 |
|
|
|
| Beijing Genomics Institute |
| http://http://www.bgisequence.com/home/ |
| |
| Address: | Beishan industrial zone, yantian district
Shenzhen - 518083 |
| Contact: | Michelle Wang |
| Email: |  |
Company description:
BGI (formerly known as Beijing Genomics Institute) was founded in Beijing on Sept 9th, 1999, with the mission of supporting the development of science and technology, building strong research teams, and promoting the development of commercial scientific services.
With a goal of excellence, high efficiency, and accuracy, BGI has successfully completed a large numerous projects. These include sequencing 1% of the human genome for the International Human Genome Project; contributing 10% to the International Human HapMap Project; carrying out research to combat SARS; being a key player in the Sino-British Chicken Genome Project; and completely sequencing the rice genome, the silkworm genome; the first Asian diploid genome, the giant panda genome, and many more. Much of this research has been published in the top international academic journals Nature and Science and can be found in our Projects section. In conjunction with carrying out these projects, BGI has established its own technical platforms based on large-scale genomic sequencing, efficient bioinformatics analyses and innovative genetic health care initiatives. These distinguished achievements have made a great contribution to the development of genomics in both China and the world, and have established BGI as a world-class research institution. In the course of attaining these goals, BGI has undergone a historic breakthrough from a small sequencing center in 1999 to the largest genomics institute in Asia in 2009, and become one of the leading genomics institutes in the world.
Throughout its short history, BGI has created an institutional structure that is characterized by systematization and innovation, institutional integration, technological platform development and product commercialization. This collaborative system, all of which is powered by the study of genomics, enables BGI to rapidly move from basic research to application.
On April 27th, 2010, BGI Americas was founded and set up its main office in Boston, MA, U.S.A. BGI Americas offers scientific and technological collaboration and services to all countries in North, Central, and South America, provides R&D in technology and product development, and seeks opportunities of cooperative projects in the fields of sequencing and bioinformatics.
May 17th 2010, the Sino-Danish Economic Cooperation Forum and the business contract signing ceremony was held in Copenhagen. The Chinese Minister of Commerce Mr. Deming Chen and the Danish Minister of Economic Department of Commerce Mr. Brain Mikkelsen, Professor Songgang Li, the associated director of BGI, signed the business contract and officially announced the set up of BGI Europe in Copenhagen, Denmark. The total registered capital of BGI Europe is 5 million DKK (about 860,000 USD) and plan to be added to 10 million DKK in 2011. Copenhagen, as headquarter of BGI-Europe, expects to establish a high-throughput sequencing platform within two years, to set up a production base in Europe and then outreach to all countries in Europe, collaborating research institutes and universities to establish joint labs in related areas. BGI-Europe will provide all European partners the opportunities in technology development, production design and project development, in fields of scientific research, agriculture and bioenergy, personal healthcare etc. The vision is to make BGI Europe one of the largest centers of sequencing and bioinformatics analysis in Europe.
Vacancies:
|
|
|
|
|
|
|
